Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 244

1.

Sexual behavioral correlates with HSV-2 seroprevalence among pregnant women in Nigeria.

Kalu EI, Ojide CK, Fowotade A, Nwadike VU.

J Infect Dev Ctries. 2014 Aug 13;8(8):1006-12. doi: 10.3855/jidc.4336.

2.

Structural and community-level interventions for increasing condom use to prevent the transmission of HIV and other sexually transmitted infections.

Moreno R, Nababan HY, Ota E, Wariki WM, Ezoe S, Gilmour S, Shibuya K.

Cochrane Database Syst Rev. 2014 Jul 29;7:CD003363. doi: 10.1002/14651858.CD003363.pub3. Review.

PMID:
25072817
3.

Use of HIV and HSV-2 biomarkers in sub-saharan adolescent prevention research: a comparison of two approaches.

Luseno WK, Hallfors DD, Cho H, Iritani BJ, Adze J, Rusakaniko S, Mbai I, Milimo B, Hobbs M.

J Prim Prev. 2014 Jun;35(3):181-91. doi: 10.1007/s10935-014-0343-6.

4.

Daily oral emtricitabine/tenofovir preexposure prophylaxis and herpes simplex virus type 2 among men who have sex with men.

Marcus JL, Glidden DV, McMahan V, Lama JR, Mayer KH, Liu AY, Montoya-Herrera O, Casapia M, Hoagland B, Grant RM.

PLoS One. 2014 Mar 17;9(3):e91513. doi: 10.1371/journal.pone.0091513. eCollection 2014.

5.

Epidemiology of genital herpes simplex virus type 1 and 2 infections in southwestern Finland during a 10-year period (2003-2012).

Kortekangas-Savolainen O, Orhanen E, Puodinketo T, Vuorinen T.

Sex Transm Dis. 2014 Apr;41(4):268-71. doi: 10.1097/OLQ.0000000000000101.

PMID:
24622640
6.

A perfect storm: crack cocaine, HSV-2, and HIV among non-injecting drug users in New York City.

Des Jarlais DC, McKnight C, Arasteh K, Feelemyer J, Perlman DC, Hagan H, Dauria EF, Cooper HL.

Subst Use Misuse. 2014 Jun;49(7):783-92. doi: 10.3109/10826084.2014.880176. Epub 2014 Feb 6.

PMID:
24502371
7.

Kaposi`s sarcoma associated herpesvirus infection among female sex workers and general population women in Shanghai, China: a cross-sectional study.

Zhang T, Yang Y, Yu F, Zhao Y, Lin F, Minhas V, Wood C, He N.

BMC Infect Dis. 2014 Feb 5;14:58. doi: 10.1186/1471-2334-14-58.

8.

HSV-2 co-infection as a driver of HIV transmission among heterosexual non-injecting drug users in New York City.

Des Jarlais DC, Arasteh K, McKnight C, Perlman DC, Feelemyer J, Hagan H, Cooper HL.

PLoS One. 2014 Jan 31;9(1):e87993. doi: 10.1371/journal.pone.0087993. eCollection 2014.

9.

HSV-2 incidence by sex over four age periods to age 38 in a birth cohort.

Dickson N, Righarts A, van Roode T, Paul C, Taylor J, Cunningham AL.

Sex Transm Infect. 2014 May;90(3):243-5. doi: 10.1136/sextrans-2013-051235. Epub 2013 Dec 13.

PMID:
24337730
10.

Etiology of genital ulcer disease and association with HIV infection in Malawi.

Phiri S, Zadrozny S, Weiss HA, Martinson F, Nyirenda N, Chen CY, Miller WC, Cohen MS, Mayaud P, Hoffman IF.

Sex Transm Dis. 2013 Dec;40(12):923-8. doi: 10.1097/OLQ.0000000000000051.

PMID:
24220352
11.

Prevalence of HIV, human papillomavirus type 16 and herpes simplex virus type 2 among female sex workers in Guinea and associated factors.

Aho J, Koushik A, Coutlée F, Diakité SL, Rashed S.

Int J STD AIDS. 2014 Mar;25(4):280-8. doi: 10.1177/0956462413500242. Epub 2013 Aug 28.

PMID:
24216036
12.

Behavioral interventions for improving condom use for dual protection.

Lopez LM, Otterness C, Chen M, Steiner M, Gallo MF.

Cochrane Database Syst Rev. 2013 Oct 26;10:CD010662. doi: 10.1002/14651858.CD010662.pub2. Review.

PMID:
24163112
13.

Avidity of antibodies against HSV-2 and risk to neonatal transmission among Mexican pregnant women.

Herrera-Ortiz A, Conde-Glez CJ, Vergara-Ortega DN, García-Cisneros S, Olamendi-Portugal ML, Sánchez-Alemán MA.

Infect Dis Obstet Gynecol. 2013;2013:140142. doi: 10.1155/2013/140142. Epub 2013 Aug 6.

14.

Genital warts in 250 Iranian patients and their high- risk sexual behaviors.

Soori T, Hallaji Z, Noroozi-Nejad E.

Arch Iran Med. 2013 Sep;16(9):518-20. doi: 013169/AIM.007.

15.

Herpes simplex virus type 2 incidence and associated risk factors among female sex workers in a high HIV-prevalence area of China.

Wang H, Reilly KH, Smith MK, Brown K, Jin X, Xu J, Ding G, Zang C, Wang J, Wang N.

Int J STD AIDS. 2013 Jun;24(6):441-6. doi: 10.1177/0956462412472800. Epub 2013 Jun 24.

PMID:
23970745
16.

Partner-concurrency associated with herpes simplex virus 2 infection in young South Africans.

Kenyon C, Colebunders R, Buve A, Hens N.

Int J STD AIDS. 2013 Oct;24(10):804-12. doi: 10.1177/0956462413482810. Epub 2013 Jul 19.

PMID:
23970590
17.

Medical male circumcision and herpes simplex virus 2 acquisition: posttrial surveillance in Kisumu, Kenya.

Mehta SD, Moses S, Agot K, Maclean I, Odoyo-June E, Li H, Bailey RC.

J Infect Dis. 2013 Dec 1;208(11):1869-76. doi: 10.1093/infdis/jit371. Epub 2013 Jul 30.

18.

Modeling the synergy between HSV-2 and HIV and potential impact of HSV-2 therapy.

Feng Z, Qiu Z, Sang Z, Lorenzo C, Glasser J.

Math Biosci. 2013 Oct;245(2):171-87. doi: 10.1016/j.mbs.2013.07.003. Epub 2013 Jul 11.

PMID:
23850537
19.

Association of Chlamydia trachomatis infection and herpes simplex virus type 2 serostatus with genital human papillomavirus infection in men: the HPV in men study.

Alberts CJ, Schim van der Loeff MF, Papenfuss MR, da Silva RJ, Villa LL, Lazcano-Ponce E, Nyitray AG, Giuliano AR.

Sex Transm Dis. 2013 Jun;40(6):508-15. doi: 10.1097/OLQ.0b013e318289c186.

20.

A cross-sectional study of sexually transmitted pathogen prevalence and condom use with commercial and noncommercial sex partners among clients of female sex workers in southern India.

Shaw SY, Bhattacharjee P, Isac S, Deering KN, Ramesh BM, Washington R, Moses S, Blanchard JF.

Sex Transm Dis. 2013 Jun;40(6):482-9. doi: 10.1097/OLQ.0b013e3182904a9a.

PMID:
23677022
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk